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Background: Celiac Disease (CD) is an increasingly common autoimmune disorder. It requires a strict lifelong
adherence to a gluten-free diet (GFD) which can influence health-related quality of life (HRQOL). This study assesses
HRQOL in children and adolescents with CD and explores how several demographic and clinical characteristics and
GFD adherence affect their perceived health status.
Methods: We recruited 140 consecutive children and adolescents with CD confirmed by small bowel biopsy.
HRQOL was assessed using the SF-12 questionnaire plus some CD-specific questions exploring wellbeing and
lifestyle. Patients, aged 10 to 18 years, were identified by pediatric gastroenterologists and guided in filling out the
questionnaire by trained psychologists. Parametric or non-parametric tests were applied to analyze continuous
variables and frequencies as appropriate.
Results: The SF-12 mean mental component summary score (MCS12) was lower than in the general Italian population
(p < 0.001), whereas differences in terms of physical health were not significant (p = 0.220). More than one third of
those interviewed reported feeling angry “always” or “most of the time” about having to follow the GFD, and nearly
20% reported feeling different from others and misunderstood because of CD “always” or “most of the time”.
Conclusions: Our findings highlight the need for health professionals to identify adolescents with major
disease-related problems. The food industry should improve its range of gluten-free food products and public
bodies and institutions should promote informative campaigns and help promote the overall quality of life of
children and adolescents with CD.Background
Coeliac disease (CD) is an immune-mediated systemic
disorder triggered by the ingestion of gluten and related
prolamines in genetically susceptible individuals [1]. It
has been demonstrated that CD is one of the most frequent
chronic childhood disorders, with a prevalence of approxi-
mately 1% in Western countries [2,3].
The only treatment for CD is avoidance of gluten-
containing food. Lifelong compliance with a gluten-free
diet (GFD) is crucial for prevention of long-term com-
plications, disappearance of medical symptoms, and full
histological and serological remission [2,4]. However,* Correspondence: emma.altobelli@cc.univaq.it
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reproduction in any medium, provided the orstrict GFD adherence has the potential to affect patients’
lifestyle hence quality of life (QoL).
Studies of the impact of CD and GFD on health-related
quality of life (HRQOL) have yielded conflicting results:
whereas according to some Swedish [5,6], Canadian [7]
and US [8] studies average HRQOL in adult patients
was comparable to that of the general population, in-
vestigations conducted in Italy [9], Germany [10] and
Northern Ireland [11] found a decreased HRQOL. How-
ever, the different methods used to measure HRQOL
in the various studies limit comparability [12]. Several
factors associated with a reduced HRQOL have been
described in CD patients [13]; they include gender (female)
[14,15], poor GFD adherence [9,16], older age at diag-
nosis [17], delayed CD diagnosis [18] and absence of
symptoms [19].l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Altobelli et al. Health and Quality of Life Outcomes 2013, 11:204 Page 2 of 9
http://www.hqlo.com/content/11/1/204Finally, studies involving children and adolescents are
few. Although most QoL studies have examined adult CD
patients, the disease clearly affects children and adolescents’
HRQOL too [19]. A considerable portion of these patients
struggle to accept GFD, particularly adolescents aged 12
to 17 years [17].
This study assesses HRQOL in children and adolescents
with CD and explores how several demographic and




Recruitment took place from January 1 2011 to March
31, 2012.
Participants were Caucasian children and adolescents
aged 10–18 years residing in Abruzzo (central Italy).
They had a diagnosis of CD confirmed by small bowel
biopsy according to the protocol of the European Society
of Pediatric Gastroenterology, Hepatology and Nutrition,
where small bowel biopsy followed by favorable clinical
and serological response to GFD is considered suffi-
cient to confirm the diagnosis [1]. Consecutive patients
identified by pediatric gastroenterologists in the hospitals
of the four Abruzzo provinces (L’Aquila, Pescara, Teramo
and Chieti) were contacted by telephone and offered par-
ticipation in the study. Those suffering from severe or ter-
minal illnesses that might prevent participation were
excluded. Participants were divided into groups of 10–20
and guided in filling out the questionnaire by trained psy-
chologists. Written, informed consent was obtained from
those of age (18 years) and from parental figures of
minors. Strict anonymity was maintained via de-identi-
fication of data. The collected data were stored on a
password-protected database.
Data collection
For data collection we adopted the “Canadian Coeliac
Health Survey”—a questionnaire developed by the
Canadian Coeliac Association and the Medical University
of Ottawa used in the study by Rashid et al. [20]—modified
and improved based on the results of a pilot study of a
group of teenagers followed at San Salvatore pediatric
hospital (L’Aquila). Their data were not included in the
analysis.
HRQOL was assessed using the Italian language version
of the “Questionnaire on the Health Status SF-12 [21].
This questionnaire is constructed to measure 8 dif-
ferent domains: four refer to the area of physical health
(Physical Functioning, Role Limitation-Physical, Bodily
Pain, General Health) and four to mental health (Role
Limitation-Emotional, Vitality, Mental Health, Social
Functioning). Two synthesized indexes are derived from
these 8 domains: one related to physical health (PCS12),the other to mental health (MCS12). Both summary scores
are standardized to have a mean of 50 and standard
deviation of 10, higher scores indicating better health
perception.
To illustrate the effect of CD on the HRQOL of ado-
lescents we compared our results with Italian normative
values from a study conducted by ISTAT on a sample
of 61,434 subjects, 3,221 (5.2%) of whom were aged
14–17 years [21]. Our questionnaire also included a set
of specific questions about the wellbeing and lifestyle
of children and adolescents with CD and their families
regarding personal issues, social activities and potential
interventions they felt would improve the QoL of celiac
patients.
The self-report questionnaire was divided into two sec-
tions. One was administered to children and adolescents
with CD, with items regarding social and demographic
data, clinical symptoms at presentation, previous misdiag-
noses, adherence to diet, and QoL and ways to improve it.
The other was administered to pediatric gastroenterolo-
gists and solicited data on clinical features, to validate and
broaden the information reported by patients. Children
aged 10–13 years were helped by parents only in com-
pleting the sections related to demographic information
and clinical features.
Statistical analysis
The following parameters were used to estimate sample
size: sample error = 0.06, event occurrence proportion
0.5 (in the case of maximum variability), probability 1-
alpha = 0.95. This yielded a sample size of 136.1.
Continuous variables, presented as mean ± standard
deviation (SD), were compared using Student’s t-test. The
Kolmogorov-Smirnov test was performed in advance to
check the normality of variables. The χ2 test was used to
estimate the association between the categorical variables
under study. Wilcoxon’s test and the Kruskal-Wallis test
were applied to interval and ordinal variables. Logistic
regression analysis was applied to evaluate whether
there was a relationship between the HRQOL reduc-
tion and the variables examined. A value of p < 0.05
was considered statistically significant. SAS software,
version 9.1.3 (SAS Institute, Cary, NC, USA), was used
for the statistical analyses.
Results
Patients
For this study, 140 individuals with biopsy-confirmed
CD were interviewed. All those who were invited to
participate agreed to do so. The mean age of patients
was 14.2 years (± SD 2.5); the majority were female
(n = 110, 78.6%). Participants were divided into two
age groups: children, aged 10–13 years (n = 63, 45.0%)
and adolescents, aged 14–18 years (n = 77, 55.0%).
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listed and compared in Table 1.
Mean age at diagnosis was 7.7 years (± SD 4.1) (males:
9.5 ± SD 3.6; females: 7.2 ± SD 4.2) with an average latency
between symptom onset and CD diagnosis of 14.2 months
(± SD 19.3). Fifty participants (35.7%) had received a pre-
vious diagnosis: anaemia and irritable bowel syndrome
were the more common diagnoses (both 28.0%). Reported
symptoms at presentation are listed in Figure 1.
In our sample, 39 participants (29.3%) were symptomatic
at the time of diagnosis, and 94 (70.7%) were asymp-
tomatic (data missing in 7 cases). A large proportion of
symptomatic patients reported gastrointestinal symp-
toms after ingestion of gluten-containing food. Specific-
ally, 26 (74.3%) patients reported diarrhea, 25 (71.4%)
reported abdominal pain and 15 (42.9%) reported bloating
and gas.Table 1 Demographic and clinical features of the sample: com
Features All cases (%)
10-13 years
Gender
Males 30 (21.4) 12 (19
Females 110 (78.6) 51 (80
Age at diagnosis
0-6 years 64 (45.7) 33 (52
≥ 7 years 76 (54.3) 30 (47
Symptoms*
Symptomatic 39 (27.9) 22 (37
Asymptomatic 94 (67.1) 36 (62
Compliance
Strict 122 (87.1) 60 (95
A little/none 18 (12.9) 3 (4.
Difficulty in compliance
A lot 16 (11.4) 9 (14
Somewhat 27 (19.3) 8 (12
A little 58 (41.4) 21 (33
None 39 (27.9) 25 (39
Duration of disease
0-3.5 years 40 (28.6) 22 (34
3.6-8 years 47 (33.6) 20 (31
8.1-18 years 53 (37.8) 21 (33
Previous misdiagnoses
Yes 50 (35.7) 14 (22
No 90 (64.3) 49 (77
Delay in making the diagnosis**
0-12 months 81 (57.9) 33 (64
≥ 13 months 41 (29.3) 18 (35
* = 7 data missing. ** = 18 data missing.Compliance with GFD
Almost all (97.9%) patients were advised to follow a GFD
by their gastroenterologist. Strict adherence was reported
by 122 (87.1%). Of these, 101 (73.2%) found a health bene-
fit. Most found adherence to the diet to be “not difficult”
(27.9%), or “a little difficult” (41.4%), while only 16 (11.4%)
found adherence to be “extremely difficult” and 27 (19.3%)
“quite difficult”. Ninety-eight (70.0%) subjects reported
using the CD handbook to learn about the presence of
gluten in food; 15.7% never used it and 14.3% did so
“only sometimes”. Looking at the two age groups, chil-
dren (aged 10–13 years) reported better compliance
compared to older ones (p = 0.02) and less difficulty in
adhering to the GFD (p = 0.01). Strict GFD compliance was
reported by 95.2% of children, while 80.5% of adolescents
did so. Additionally, 39.7% of children found GFD
compliance to be “not difficult”, while only 18.2% ofparison between age groups
Age groups
p



























Figure 1 Clinical symptoms at CD presentation.
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ference in the use of the CD handbook was found
between the two groups.
Quality of life
We assessed the QoL of adolescents with CD and the
perception of how the disease influenced their social and
personal life. Their mean PCS12 was 54.00 ± SD 5.00
and their mean MCS12 was 49.16 ± SD 10.61. The two
summary scores were not normally distributed in each
group (both p-values < 0.001).
To compare these data with Italian normative values,
we looked only at the adolescent age group of the ISTAT
study (14–17 years) [15]. No differences were observed
in the physical health area (Table 2), whereas in the
mental health area our sample showed a lower MCS12
score (p < 0.001). As shown in Table 2 the same differenceTable 2 Quality of Life: comparison between participants’ SF-
No. (%) PCS12 mean ± SD
Age group 14–17 years
Italian average 3221 (5.2) 54.90 ± 4.69
Sample 64 (45.7) 54.11 ± 5.07
Males (14–17 years)
Italian average 1658 (51.5) 54.97 ± 4.58
Sample 17 (26.6) 53.83 ± 5.43
Females (14–17 years)
Italian average 1563 (48.5) 54.82 ± 4.80
Sample 47 (73.4) 54.21 ± 4.99was observed in both genders (males: p = 0.03; females:
p < 0.001).
We estimated the association between several variables
and the scores of the sample on the physical and mental
synthesized indexes of the SF-12. No differences were
observed between genders, age groups, duration of
disease categories, age at diagnosis, diagnostic difficul-
ties (previous misdiagnoses and delays in making the diag-
nosis) or symptomatology at the time of diagnosis
(data not shown). Compliance did not influence SF-12
results either. With regard to the perceived degree of dif-
ficulty in GFD compliance, those subjects who reported
more difficulties had a lower MCS12 score, but the p-value
was not significant (p = 0.08, data not shown).
The results of the binary logistic regression analysis are
reported in Table 3. The independent variables analyzed
did not significantly affect PCS12 or MCS12.12 score and Italian normative values
P MCS12 mean ± SD p
0.22 54.05 ± 7.89 < 0.001
48.45 ± 10.01
0.40 55.17 ± 6.96 0.03
50.93 ± 8.39
0.41 52.87 ± 8.62 < 0.001
47.55 ± 10.47
Table 3 Logistic regression analysis of factors predicting a reduced health-related quality of life as measured by the
SF-12, in children and adolescents with CD
Synthesized indexes Independent variables Odds ratio 95% CI β p
PCS12 Gender 0.79 0.26-2.41 0.23 0.68
Age groups 1.03 0.41-2.55 0.03 0.96
Age at diagnosis 1.05 0.42-2.63 0.05 0.92
Symptoms
Compliance 1.04 0.29-3.78 0.04 0.95
Difficulty in compliance 1.80 0.29-3.78 0.04 0.95
Duration of disease
Previous misdiagnoses 1.14 0.45-2.86 0.13 0.78
Delay in making the diagnosis
MCS12 Gender 1.27 0.53-3.07 0.24 0.59
Age groups 0.79 0.37-1.72 0.23 0.56
Age at diagnosis 0.98 0.45-2.14 0.02 0.96
Symptoms
Compliance 0.91 0.30-2.74 0.10 0.87
Difficulty in compliance 1.55 0.68-3.55 0.44 0.30
Duration of disease
Previous misdiagnoses 1.07 0.49-2.31 0.06 0.87
Delay in making the diagnosis
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being and lifestyle of children and adolescents with CD
are summarized in Table 4. When looking at the age
groups, no differences were observed in avoiding restau-
rants or in travel. Conversely, 14.3% of children reported
bringing gluten-free food while travelling only “some of the
time” or “never”, while only 2.6% of the older ones did so
(p = 0.01). Difficulty in finding gluten-free food in stores
was reported more frequently by adolescents (p < 0.01), as
was difficulty in finding high-quality food (p = 0.03). On
the other hand, children felt left out of activities more
often than their older counterparts (p = 0.03). Gender
did not influence most of the items, but girls felt more
embarrassed about bringing gluten-free food to parties
(p = 0.01, data not shown) and felt left out of activities
more often (p = 0.02, data not shown). Division of the sam-
ple into symptomatic and asymptomatic patients yielded no
difference in most of the items, except that symptomatic
children and adolescents felt that they were not invited out
for meals because of CD more often than asymptomatic
ones (p < 0.01, data not shown), and worried more about
staying in hospital because of CD (p < 0.001). Conversely,
asymptomatic children and adolescents felt more often that
they could be healthy without following a GFD (p = 0.01,
data not shown). The analysis of age at diagnosis groups
(0–6 years, ≥ 7 years) revealed no differences in the above
items (data not shown).Keys to improve quality of life
Finally, participants were asked to choose from a list
(not reported here) two items that could improve QoL
for themselves and their families. The most frequent ele-
ment chosen was “gluten-free choices in restaurants”,
which was selected by 68.8% of participants; “gluten-free
choices in supermarkets” was chosen by 36.0% and
“informative campaigns in all social contexts” (e.g. schools,
restaurants) by 36.6%; 32.9% of patients selected “better
labelling”; 22.8% chose “earlier diagnosis”, and only
2.9% chose “better dietetic counseling”.
Discussion
In this study we assessed the HRQOL and psychosocial
wellbeing of 140 children and adolescents with CD from
140 families residing in Abruzzo (central Italy). To evaluate
the CD features and treatment aspects that impact
these outcomes most, we also assessed age at diagno-
sis, symptoms at presentation, diagnostic difficulties,
disease duration, and compliance with the diet and re-
lated difficulties.
Mean age at diagnosis (7.7 years) was higher than that
found by Rashid et al. (4.8 years) [20], but consistent
with trends reported by Walker-Smith and March [22],
highlighting an increasing age at presentation of children
with CD throughout Europe. Our findings highlight that
children present with a variety of signs and symptoms.
Table 4 Children and adolescents perception of social
and personal impairment
All cases Age groups
p
No. (%)
10-13 years 14-18 years
No. (%) No. (%)
Avoided restaurants
All the time 11 (7.9) 5 (7.9) 6 (7.8) 0.77
Most of the time 32 (22.9) 13 (20.6) 19 (24.7)
Some of the time 50 (35.7) 21 (33.4) 29 (37.6)
Never 47 (33.5) 24 (38.1) 23 (29.9)
Avoided traveling
All the time 4 (2.9) 0 (0.0) 4 (5.2) 0.14
Most of the time 7 (5.0) 4 (6.4) 3 (3.9)
Some of the time 24 (17.1) 8 (12.7) 16 (20.8)
Never 105 (75.0) 51 (80.9) 54 (70.1)
Brought gluten-free food while traveling
All the time 114 (81.4) 52 (82.5) 62 (80.5) 0.01
Most of the time 15 (10.7) 2 (3.2) 13 (16.9)
Some of the time 9 (6.5) 7 (11.1) 2 (2.6)
Never 2 (1.4) 2 (3.2) 0 (0.0)
Found it hard to find gluten-free food in groceries
All the time 16 (11.4) 6 (9.5) 10 (13.0) < 0.01
Most of the time 19 (13.6) 9 (14.3) 10 (13.0)
Some of the time 66 (47.1) 21 (33.4) 45 (58.4)
Never 39 (27.9) 27 (42.8) 12 (15.6)
Found it hard to find good quality gluten-free food
All the time 15 (10.7) 4 (6.3) 11 (14.3) 0.03
Most of the time 21 (15.0) 9 (14.3) 12 (15.6)
Some of the time 61 (43.6) 23 (36.5) 38 (49.3)
Never 43 (30.7) 27 (42.9) 16 (21.8)
Found it difficult to determine if foods were gluten-free from labels
All the time 6 (4.3) 4 (6.3) 2 (2.6) 0.10
Most of the time 28 (20.0) 11 (17.5) 17 (22.0)
Some of the time 43 (30.7) 14 (22.2) 29 (37.7)
Never 63 (45.0) 34 (54.0) 29 (37.7)
Felt left out of activities at school or friend’s home
All the time 6 (4.3) 3 (4.8) 3 (3.9) 0.03
Most of the time 5 (3.6) 5 (7.9) 0 (0.0)
Some of the time 30 (21.4) 9 (14.3) 21 (27.3)
Never 99 (70.7) 46 (73.0) 53 (68.8)
Felt different from others cause of celiac disease
All the time 14 (10.0) 7 (11.1) 7 (9.1) 0.44
Most of the time 15 (10.7) 8 (12.7) 7 (9.1)
Some of the time 47 (33.6) 24 (38.1) 23 (29.9)
Never 64 (45.7) 24 (38.1) 40 (51.9)
Table 4 Children and adolescents perception of social
and personal impairment (Continued)
Felt embarrassed to bring gluten-free food to parties
All the time 35 (25.0) 18 (28.6) 17 (22.1) 0.03
Most of the time 15 (10.7) 5 (7.9) 10 (12.9)
Some of the time 34 (24.3) 9 (14.3) 25 (32.5)
Never 56 (40.0) 31 (49.2) 25 (32.5)
Felt angry about the need to adhere to diet
All the time 29 (20.7) 10 (15.9) 19 (24.7) 0.14
Most of the time 21 (15.0) 9 (14.3) 12 (15.6)
Some of the time 46 (32.9) 18 (28.6) 28 (36.4)
Never 44 (31.4) 26 (42.2) 18 (22.4)
Felt that teachers and friends did not understand
All the time 6 (4.3) 2 (3.2) 4 (5.2) 0.65
Most of the time 21 (15.0) 9 (14.3) 12 (15.6)
Some of the time 52 (37.1) 21 (33.3) 31 (40.2)
Never 61 (43.6) 31 (49.2) 30 (39.0)
Thought of being a burden for someone because of celiac disease
All the time 10 (7.1) 5 (7.9) 5 (6.5) 0.42
Most of the time 16 (11.4) 6 (9.5) 10 (13.0)
Some of the time 46 (32.9) 17 (27.0) 29 (36.7)
Never 68 (48.6) 35 (55.6) 33 (42.8)
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disease screening, because narrow thresholds may cause
cases to be missed [4,22]. Although it is well known that
CD is a common chronic childhood disorder, timely
diagnosis is still lagging behind and the average interval
between symptom onset and diagnosis remains long
(14.2 months). Furthermore, one third of our sample
reported previous incorrect diagnoses. Moreover, diag-
nosis by clinical signs only is impossible in many cases,
because a large portion of CD patients are asympto-
matic. It has been estimated that only 1 in 3 to 1 in 7
patients with CD are symptomatic [23,24]; the propor-
tion of symptomatic patients in our study is consistent
with the literature (29.3%).
In our sample 87.1% of participants reported “strict
adherence” to GFD. Compliance was less “strict” than
that reported by Rashid et al. (95%), but higher than the
one found in a study conducted in Austria in 2008 [17]
and in other European studies [14,25]. This could be
due to the mean age of our sample (14.2 years), which
is higher than that of the sample investigated by Rashid
et al. (9 years), but similar to that of the Austrian
(14.8 years) and the other European studies, where
mean ranged from 14 years to “young adults”. In this
regard, a Swedish study reported lower compliance
among adolescents aged 15–17 years than among younger
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these data.
HRQOL has attracted considerable scientific interest
in recent years. QoL is described as a perception of
health and wellbeing impacting all aspects of our lives.
Numerous studies have investigated the influence of GFD
on the HRQOL of the coeliac population [14,15,26,27]
and have recognized that eating does not merely meet
physiological needs: food has a symbolic value both in cul-
tural terms and in the intra-psychic and relational aspects
associated with it.
In general a decreased HRQOL is observed, especially
in the social domain, but many questions remain con-
cerning the impact of GFD on children and adolescents
[28]. Our findings show impairment in both the mental
and social domain of HRQOL. The mean mental health
summary score (MCS12) of the SF-12 questionnaire was
lower than that of the age- and sex-matched Italian
population. Nevertheless, CD and CD treatment do
not seem to affect physical health, consistent with pre-
vious findings showing that GFD usually results in an
overall improvement in HRQOL [14,15].
Unlike other studies conducted in adults and children
[14,15], which reported poorer HRQOL in females, the
present survey found an equal burden of CD and the
diet. This is in line with a recent investigation using the
SF-36, from which the SF-12 has been obtained, con-
ducted in Germany [13]; in contrast the other studies
mentioned above used different types of questionnaires
to investigate HRQOL.
Whereas Nörstrom et al. [18] found that delayed diag-
nosis is related to a decreased HRQOL in adults, our
sample showed no difference in the physical, mental or
social HRQOL domains. This may be due to the signifi-
cantly lower average delay found in our study compared
with that of Nörstrom et al. (14.2 months vs 9.7 years).
Late diagnosis did not entail significant differences in
HRQOL in our sample. Such findings contrast with those
reported by Wagner et al. [17]; this may however be
ascribed to the different tools used to measure HRQOL,
since they used the ILC (Inventory of Life Quality in
Children and Adolescents), which found significant dif-
ferences between patients diagnosed early and late, and
the BFW (Berner Subjective Well-being Inventory) which
found no differences between the groups.
Furthermore, diagnosing asymptomatic individuals
with CD does not necessarily result in improved
HRQOL. Although many studies have reported deterio-
rated HRQOL in asymptomatic CD patients diagnosed
by screening [19,29,30], we found only minor diffe-
rences between symptomatic and asymptomatic chil-
dren and adolescents in personal issues and social
activities, and no differences in SF-12 scores, in line
with a recent study [31] that did not find a reducedHRQOL in asymptomatic adolescents detected through
screening.
Poor GFD compliance, a factor that is associated with
a reduced HRQOL in CD patients [9,16], did not relate
with a decreased HRQOL in our sample, either.
Even though most of the children and adolescents inter-
viewed adjusted well to GFD, more than one third felt
angry “always” or “most of the time” about the need to fol-
low the dietary regimen, and the same proportion felt
embarrassed bringing gluten-free food to friends’ parties.
Moreover, more than 20% of those interviewed reported
feeling different from others because of CD “always” or
“most of the time”, and 19.5% felt misunderstood. Only
one third reported not avoiding restaurants ever, but this
proportion rose to three quarters when travel was in-
volved, with 81.4% writing that they always brought
gluten-free food on journeys. Other difficulties reported
included availability of gluten-free food in grocery stores
(25% had difficulties “always” or “most of the time”), and
determining from the label whether food was gluten-free
(only 45% never succeeded). Significant differences be-
tween the age groups (10-13/14-18 years) were observed
in finding gluten-free food in groceries: the older ones re-
ported more difficulties. This may be explained by the fact
that they are more involved in buying their own food,
while younger patients rely on parents. Gender did not
significantly influence social activities, except that girls felt
left out of activities more often and felt more embarrassed
about bringing gluten-free food to parties.
Overall, our findings are consistent with those of Rashid
et al. [20] and with more recent studies [27,28] which
found that the celiac adult population adhering to GFD
reports a negative impact on HRQOL, especially in the
social domain.
Finally, as regards potential interventions that could
improve the QoL of celiac patients, the majority of those
interviewed chose gluten-free choices in restaurants, and
approximately one third chose informative campaigns in
all social contexts and better labelling.
Conclusions
Compliance with GFD results in an improvement in terms
of the physical aspects of HRQOL. However, considering
only this area fails to reveal the true extent of how gluten-
free living impacts on HRQOL. Our study highlights that
CD and its treatment result in a decreased HRQOL both
in the mental and social domains.
Increased awareness of CD as a common worldwide
public health problem [32] is needed and greater support
and education should be given to CD patients to help
them cope with the disease and its management.
In addition, as stated by children and adolescents with
CD, the food industry should provide a wider choice of
gluten-free food products, so as to make it more available
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ling. Finally, public bodies and institutions should pro-
mote CD awareness campaigns and help promote the
overall QoL of children and adolescents with CD.
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